Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Leff

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Experimental Neurology|January 12, 2000
Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's diseaseR J Mandel, R O Snyder, S E Leff
Advances in Biochemical Psychopharmacology|January 1, 1983
Dopamine receptors in the central nervous systemI Creese, D R Sibley, M W Hamblin, et al.
Annual Review of Neuroscience|January 1, 1983
The classification of dopamine receptors: relationship to radioligand bindingI Creese, D R Sibley, M W Hamblin, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 1998
Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in ratsR J Mandel, S K Spratt, R O Snyder, et al.
New York State Journal of Medicine|May 1, 1976
Intrapericardial teratomaC B Yeoh, P D Harris, E Leff, et al.
The American Journal of Medicine|May 21, 1999
Beyond the mystique of prestige: measuring the quality of residency programsJ L Bowen, L E Leff, L G Smith, et al.
Experimental Neurology|September 16, 1999
Progress in direct striatal delivery of L-dopa via gene therapy for treatment of Parkinson's disease using recombinant adeno-associated viral vectorsR J Mandel, K G Rendahl, R O Snyder, et al.
Neuroscience|July 7, 1999
Long-term restoration of striatal L-aromatic amino acid decarboxylase activity using recombinant adeno-associated viral vector gene transfer in a rodent model of Parkinson's diseaseS E Leff, S K Spratt, R O Snyder, et al.
Biochemical Society Transactions|February 1, 1987
Neuron-specific alternative RNA processing in neuroendocrine gene expressionM G Rosenfeld, S E Leff, A F Russo, et al.
International Review of Neurobiology|January 1, 1982
Dopamine receptors in the central nervous systemI Creese, A L Morrow, S E Leff, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Experimental Neurology|January 12, 2000
Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's diseaseR J Mandel, R O Snyder, S E Leff
Advances in Biochemical Psychopharmacology|January 1, 1983
Dopamine receptors in the central nervous systemI Creese, D R Sibley, M W Hamblin, et al.
Annual Review of Neuroscience|January 1, 1983
The classification of dopamine receptors: relationship to radioligand bindingI Creese, D R Sibley, M W Hamblin, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 1998
Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in ratsR J Mandel, S K Spratt, R O Snyder, et al.
New York State Journal of Medicine|May 1, 1976
Intrapericardial teratomaC B Yeoh, P D Harris, E Leff, et al.
The American Journal of Medicine|May 21, 1999
Beyond the mystique of prestige: measuring the quality of residency programsJ L Bowen, L E Leff, L G Smith, et al.
Experimental Neurology|September 16, 1999
Progress in direct striatal delivery of L-dopa via gene therapy for treatment of Parkinson's disease using recombinant adeno-associated viral vectorsR J Mandel, K G Rendahl, R O Snyder, et al.
Neuroscience|July 7, 1999
Long-term restoration of striatal L-aromatic amino acid decarboxylase activity using recombinant adeno-associated viral vector gene transfer in a rodent model of Parkinson's diseaseS E Leff, S K Spratt, R O Snyder, et al.
Biochemical Society Transactions|February 1, 1987
Neuron-specific alternative RNA processing in neuroendocrine gene expressionM G Rosenfeld, S E Leff, A F Russo, et al.
International Review of Neurobiology|January 1, 1982
Dopamine receptors in the central nervous systemI Creese, A L Morrow, S E Leff, et al.
Pageof 5